Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03705897 · ClinicalTrials.gov registry record · NA

PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings

A NA study of Colorectal Cancer, sponsored by University of Texas Southwestern Medical Center.

Active
Registry status
NA
Development phase
9,865
Enrollment target
1
Study location

NCT03705897: Active NA study of Colorectal Cancer, sponsored by University of Texas Southwestern Medical Center.

NCT03705897 is a NA study of Colorectal Cancer that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 9,865 participants, above the 1,519-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (549% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03705897, a NA study of Colorectal Cancer, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
9,865 participants
Enrollment target
1
Study location

Study Summary

The overall goal of the Parkland-UT Southwestern Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Center is to optimize colon cancer screening through personalized regimens in the integrated safety-net clinical provider network, which serves a large and diverse population of under- and un-insured patients in Dallas. Together, three research projects will assess clinic, system, and organizational factors associated with over-, under- and guideline-based screening among this important population and will compare benefits, harms, and costs of strategies for facilitating optimized screening regimens. The theme of optimizing colorectal cancer screening in a safety-net clinical provider network brings together several components. Its focus on colorectal cancer (CRC) screening which is important, because CRC is the second cancer killer in the US while being the only major cancer for which optimized screening results in primary prevention. Despite this strong potential benefit, CRC screening remains suboptimal overall, and especially among low-income and minority individuals served by safety-nets. Safety-net networks therefore offer tremendous potential for CRC prevention and control, but numerous factors at the clinics-, system-, and organization-level influence their ability to provide optimized care.

Primary Outcome

Proportion of patients achieving appropriate screening regimen.

Conditions Studied

Interventions

  • OTHER Computerized Risk Stratification Tool
  • OTHER Algorithmic Risk Stratification Tool
  • OTHER Step completion assessment

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 9,865 participants
Start Date 2013-08
Est. Completion 2026-08
Phase NA

What the registry record for NCT03705897 still lists

NCT03705897 is an interventional study that assigns participants to a tested intervention. Its 9,865 participants enrollment target places it among the larger protocols in the corpus, above the 1,519-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (549% higher).

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 3 interventions - of which Computerized Risk Stratification Tool is the first listed.

NCT03705897 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03705897 about?

NCT03705897 is a clinical study titled "PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings". The overall goal of the Parkland-UT Southwestern Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Center is to optimize colon cancer screening through personalized regimens in the integrated safety-net clinical provider network, which serves a large and diverse p...

What is the current status of trial NCT03705897?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 9,865 participants. The study started on 2013-08. Estimated completion is 2026-08.

What conditions does trial NCT03705897 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT03705897?

The interventions under investigation include: Computerized Risk Stratification Tool (OTHER), Algorithmic Risk Stratification Tool (OTHER), Step completion assessment (OTHER).

Who is sponsoring clinical trial NCT03705897?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03705897 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03705897's enrollment target sits among peer trials

9,865 9th of 381 higher than 373 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03705897, the US trial registry maintained by the National Library of Medicine. NCT03705897 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.